Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.
It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. Since many forms of breast cancer cells are stimulated by estrogen, it is hoped that by reducing amounts of estrogen in the body the progression of such a disease can be halted. This is the basic premise behind Nolvadex, except this drug blocks the action and not production of estrogen.
Wuhan Carphetin Chemical Co,.LTD is located in the beautiful Jiangxia distrit Wuhan. It is the large-scale and high-tech chemical company professional in R &D, production and sales of fine chemicals, flavors and fragrances, food additives, pharmaceutical raw materials and intermediates together.
The carphetin established enchiridion of credibility and integrity, procedure document linked to GPM certificate,created credibility and integrity management system which was focusing on QA and QC, to ...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company
Product/Service (We Buy): 51 - 100 People
Ownership Type: Partnership
Registered Capital: US$5 Million - US$10 Million
Year Established: 2014
Number of Employees: 51 - 100 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: Third Parties
Number of Production Lines: 10
Number of R&D Staff: 96
Number of QC Staff: 5 - 10 People
Total Annual Sales Volume: US$50 Million - US$100 Million
Description: Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. Femara is the second in a new class of third-generation selective oral aromatase inhibitors. It acts by blocking the enzyme aromatase, sub...